Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor Hematopoietic Stem Cell Transplant

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01012492
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:30.628548+00:00
Published At
2017-09-15T00:00:00+00:00
Record Updated At
2019-11-21
Results Posted At
2017-09-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["AML", "ALL", "Undifferentiated Leukemia", "Biphenotypic Leukemia", "Refractory Anemia", "Refractory Anemia With Ringed Sideroblasts", "Refractory Cytopenia With Multilineage Dysplasia", "Ref. Cytopenia w Multilineage Dysplasia \u0026 Ringed Sideroblasts", "Refractory Anemia With Excess Blasts-1 (5-10% Blasts)", "Refractory Anemia With Excess Blasts-2 (10-20% Blasts)", "Myelodysplastic Syndrome, Unclassified", "MDS Associated With Isolated Del (5q)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-11-21"
protocolSection.identificationModule.nctId
"NCT01012492"
protocolSection.identificationModule.officialTitle
"Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor Hematopoietic Stem Cell Transplant"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-09-15"

Study condition terms

  • AML (protocolSection.conditionsModule.conditions)
  • ALL (protocolSection.conditionsModule.conditions)
  • Undifferentiated Leukemia (protocolSection.conditionsModule.conditions)
  • Biphenotypic Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory Anemia (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Ringed Sideroblasts (protocolSection.conditionsModule.conditions)
  • Refractory Cytopenia With Multilineage Dysplasia (protocolSection.conditionsModule.conditions)
  • Ref. Cytopenia w Multilineage Dysplasia & Ringed Sideroblasts (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts-1 (5-10% Blasts) (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts-2 (10-20% Blasts) (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome, Unclassified (protocolSection.conditionsModule.conditions)
  • MDS Associated With Isolated Del (5q) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.